Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 19;14(24):6265.
doi: 10.3390/cancers14246265.

Surgical Aspects of Intrahepatic Cholangiocarcinoma

Affiliations
Review

Surgical Aspects of Intrahepatic Cholangiocarcinoma

Amram Kupietzky et al. Cancers (Basel). .

Abstract

Intrahepatic cholangiocarcinoma (ICC) is a rare and aggressive malignancy. It originates from the bile ducts and is the second most common primary cancer of the liver. Surgery is considered the only curative treatment of ICC, offering the best chance for long-term survival. The purpose of this article is to review the available literature on ICC, with a focus on the various aspects of the surgical care in this potentially lethal malignancy.

Keywords: biliary tract cancers; intrahepatic cholangiocarcinoma; surgical resection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Lymph node locations for ICC lymphadenectomy.

References

    1. Beal E.W., Tumin D., Moris D., Zhang X.F., Chakedis J., Dilhoff M., Schmidt C.M., Pawlik T.M. Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma. Hepatobiliary Surg. Nutr. 2018;7:270–276. doi: 10.21037/hbsn.2018.03.16. - DOI - PMC - PubMed
    1. Wu L., Tsilimigras D.I., Paredes A.Z., Mehta R., Hyer J.M., Merath K., Sahara K., Bagante F., Beal E.W., Shen F., et al. Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival. World J. Surg. 2019;43:1777–1787. doi: 10.1007/s00268-019-04966-4. - DOI - PubMed
    1. Florio A.A., Ferlay J., Znaor A., Ruggieri D., Alvarez C.S., Laversanne M., Bray F., McGlynn K.A., Petrick J.L. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer. 2020;126:2666–2678. doi: 10.1002/cncr.32803. - DOI - PMC - PubMed
    1. Brown K.M., Parmar A.D., Geller D.A. Intrahepatic cholangiocarcinoma. Surg. Oncol. Clin. N. Am. 2014;23:231–246. doi: 10.1016/j.soc.2013.10.004. - DOI - PMC - PubMed
    1. Van Dyke A.L., Shiels M.S., Jones G.S., Pfeiffer R.M., Petrick J.L., Beebe-Dimmer J.L., Koshiol J. Biliary tract cancer incidence and trends in the United States by demographic group, 1999–2013. Cancer. 2019;125:1489–1498. doi: 10.1002/cncr.31942. - DOI - PMC - PubMed

LinkOut - more resources